Report Information More information from: https://www.wiseguyreports.com/reports/1034773
Global Diabetic Macular Edema Therapeutics Market Size, Status and Forecast 2022 Report / Search Code: WGR1034773
Price
Description:
1-user PDF : $ 3300.0
Publish Date: 8 March, 2017
Enterprise PDF : $ 6600.0
This report studies the global Diabetic Macular Edema Therapeutics market, analyzes and researches the Diabetic Macular Edema Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Genentech USA Eyetech Pharmaceuticals Bausch & Lomb Alimera Sciences Allergan SurModics Birken AG Stratatech Corporation Fibrocell Science GlaxoSmithKline Plc InMed Pharmaceuticals Karus Therapeutics Limited RegeneRx Biopharmaceuticals Scioderm Shire Plc Stratatech Corporation Federal University of Sao Paulo HaEmek Medical Center Cornea and Laser Eye Institute Democritus University of Thrace Isfahan University of Medical Sciences Al-Noor Eye Hospital Azienda Ospedaliera-Universitaria Di Modena Azienda Ospedaliera Universitaria Senese Department of Health Emory University Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Diabetic Macular Edema Therapeutics can be split into Focal Laser Treatments Grid Laser Treatments Anti-VEGF Therapies Corticosteroid Therapies Implants Market segment by Application, Diabetic Macular Edema Therapeutics can be split into Hospitals Ambulatory Surgical Centers Ophthalmic Clinics Other